Growth effects of systemic versus inhaled steroids in chronic lung disease

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 87, Issue 1, 2002, Pages

  Nicholl, R M ^a   Greenough, A ^a   King, M ^a   Cheeseman, P ^a   Gamsu, H R ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; DEXAMETHASONE; STEROID;

ARTICLE; CHILD GROWTH; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GESTATIONAL AGE; GROWTH DISORDER; HUMAN; LEG LENGTH; LOWER LEG; MALE; MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERY LOW BIRTH WEIGHT; WEIGHT GAIN;

EID: 0036310818     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.87.1.f59     Document Type: Article

References (7)

1. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants
2. Growth retardation after dexamethasone administration: Assessment by knemometry
3. Changes in growth and metabolism in very low birthweight infants fed with fortified breast milk
4. Inhaled versus systemic steroids in chronic oxygen dependency in preterm infants
5. Trial of beclomethasone dipropionate by metered-dose inhaler in ventilator-dependent neonates less than 1500 grams
6. Knemometry and the assessment of growth in premature infants
7. Effects of inhaled beclomethasone compared to systemic dexamethasone on lung inflammation in preterm infants at risk of chronic lung disease